At the Hermanos Ameijeiras Surgical Clinical Hospital in Havana, consultations began this Wednesday to classify patients with Alzheimer's disease for their subsequent inclusion in the Phase III clinical trial with the neuroprotective drug NeuralCIM (NeuroEPO).»

Miguel Diaz-Canel Bermudez, first secretary of the Central Committee of the Cuban communist party and president of the country, marked today the 211th anniversary of Venezuela's Declaration of Independence.»

The 2nd International Renewable Energy Fair opens its doors Wednesday at Havana’s PABEXPO exhibit ground in an effort to attract foreign investment in the sector.»

Cuban health ministry ( MINSAP by its Spanish acronym)) reported today that 9 970 913 people (90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.»

Cuba's Civil Defense (DC) on Wednesday issued the first early warning due to the presence of an extensive area of low pressure and remnants of Tropical Hurricane Agatha.»

We are an empowered civil society, committed to the Revolution and dedicated to supporting the people, which is why we demand an end to the genocidal blockade of the United States and its discriminatory policy towards Cuba, said Norma Goicochea, president of the Cuban Association of the United Nations (ACNU).»

The Spanish airline company Plus Ultra will include Cuba as a destination on its summer flight schedules, said Viajes Cuba Group on its Twitter account.»

With the approval of two new laws related to the field of culture, the National Assembly of People's Power (ANPP) concluded its Fifth Extraordinary Session of the Ninth Legislature, held at the Havana Convention Center.»

he psychological care of children affected by the events at the Saratoga hotel is a priority, said Ena Elsa Velazquez Cobiella, Cuban minister of education, during a tour around the Rafael Maria de Mendive elementary school, located in the capital's Old Havana municipality.»

The director of Bio-Medical Research at Cuba’s Genetic Engineering and Biotech Center, Gerardo Guillen, said the clinical tests phase I and II for homegrown intra-nasal COVID-19 vaccine MAMBISA were successful.»